TheraCryf Alternatives & Competitors
12 companies similar to TheraCryf
Companies similar to TheraCryf
Sling Therapeutics
Focused on late-stage development of an oral small molecule for the treatment of thyroid e...
Ann Arbor, United States
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Chicago, United States
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Track all TheraCryf competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
Boston, United States
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical devel...
Spain
PNP Therapeutics, Inc.
Clinical-stage biopharmaceuticals developing cancer treatment platform with proprietary pr...
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
San Diego, United States
Novaliq GmbH
Transforming Ocular Therapeutics
Heidelberg, Germany
About TheraCryf
TheraCryf is a clinical-stage therapeutics company, strategically positioning itself at the forefront of innovation in oncology and behavioral brain disorders. Originally known as Evgen Pharma plc, the company's recent acquisition of Chronos Therapeutics in April 2024 has broadened its mission and enhanced its portfoli...
Drug Discovery, Pre-clinical Development, Clinical Collaboration, Regulatory Submissions
Mid-size to Large Pharmaceutical Companies, Patients with Brain Disorders, Healthcare Providers, Scientific Research Institutions
Clinical Stage Drug Development, Cancer Treatment, Neurological Disease Treatment, Sulforadex® Technology, Sulforaphane Analogues, Medical Potential, Peer-reviewed Scientific Papers, Therapeutic Compounds, Biopharmaceutical, Clinical Research, Commercial Product Development
B2B, B2D
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches TheraCryf and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at TheraCryf on 11 Mar 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
